Aardvark Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Aardvark Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on August 14, 2026, with key proposals including director elections, auditor ratification, and stock option repricing.